首页> 美国卫生研究院文献>World Journal of Gastrointestinal Endoscopy >Submucosal tunnel endoscopy: Peroral endoscopic myotomy and peroral endoscopic tumor resection
【2h】

Submucosal tunnel endoscopy: Peroral endoscopic myotomy and peroral endoscopic tumor resection

机译:黏膜下隧道内镜检查:经内镜下肌切开术和经内镜下肿瘤切除术

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peroral endoscopic myotomy (POEM) is an innovative, minimally invasive, endoscopic treatment for esophageal achalasia and other esophageal motility disorders, emerged from the natural orifice transluminal endoscopic surgery procedures, and since the first human case performed by Inoue in 2008, showed exciting results in international level, with more than 4000 cases globally up to now. POEM showed superior characteristics than the standard 100-year-old surgical or laparoscopic Heller myotomy (LHM), not only for all types of esophageal achalasia [classical (I), vigorous (II), spastic (III), Chicago Classification], but also for advanced sigmoid type achalasia (S1 and S2), failed LHM, or other esophageal motility disorders (diffuse esophageal spasm, nutcracker esophagus or Jackhammer esophagus). POEM starts with a mucosal incision, followed by submucosal tunnel creation crossing the esophagogastric junction (EGJ) and myotomy. Finally the mucosal entry is closed with endoscopic clip placement. POEM permitted relatively free choice of myotomy length and localization. Although it is technically demanding procedure, POEM can be performed safely and achieves very good control of dysphagia and chest pain. Gastroesophageal reflux is the most common troublesome side effect, and is well controllable with proton pump inhibitors. Furthermore, POEM opened the era of submucosal tunnel endoscopy, with many other applications. Based on the same principles with POEM, in combination with new technological developments, such as endoscopic suturing, peroral endoscopic tumor resection (POET), is safely and effectively applied for challenging submucosal esophageal, EGJ and gastric cardia tumors (submucosal tumors), emerged from muscularis propria. POET showed up to know promising results, however, it is restricted to specialized centers. The present article reviews the recent data of POEM and POET and discussed controversial issues that need further study and future perspectives.
机译:经口内镜下肌切开术(POEM)是一种创新的,微创的内镜治疗食管性门失弛缓症和其他食道运动性疾病的方法,源于自然孔腔内镜手术,自Inoue于2008年进行首例人类病例以来,结果显示国际水平,到目前为止,全球有4000余例。 POEM显示出比标准的具有100年历史的手术或腹腔镜Heller肌切开术(LHM)更好的特征,不仅适用于所有类型的食道门失弛缓症[经典(I),剧烈(II),痉挛(III),芝加哥分类],但也适用于晚期乙状结肠type门失弛缓症(S1和S2),LHM失败或其他食道运动障碍(食道弥漫性食管痉挛,胡桃夹子食道或Jackhammer食道)。 POEM首先从粘膜切口开始,然后穿过食管胃交界处(EGJ)进行肌膜切开术。最后,通过内窥镜夹子放置封闭粘膜入口。 POEM允许相对自由地选择肌切开术的长度和位置。尽管在技术上要求很高,但是POEM可以安全地执行,并且可以很好地控制吞咽困难和胸痛。胃食管反流是最常见的麻烦副作用,可以通过质子泵抑制剂很好地控制。此外,POEM开启了粘膜下隧道内窥镜检查的时代,并具有许多其他应用。基于与POEM相同的原理,结合内窥镜缝合,经口内窥镜肿瘤切除术(POET)等新技术的发展,安全有效地用于应对挑战性的粘膜下食管,EGJ和胃card门肿瘤(粘膜下肿瘤)固有肌层。 POET表现出知道有希望的结果,但是,它仅限于专业中心。本文回顾了POEM和POET的最新数据,并讨论了有争议的问题,需要进一步研究和展望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号